流感病毒神经氨酸酶抑制剂的研究进展
摘要
流感病毒在感染和传播过程中,神经氨酸酶(NA)起到了关键作用,因此,神经氨酸(即唾液酸)已成为设计、合成流感病毒神经氨酸酶抑制剂(NAIs)的重要先导化合物和模版分子。文中综述了抗流感病毒唾液酸类NAIs的研究进展。
出处
《华西药学杂志》
CAS
CSCD
2015年第1期113-116,共4页
West China Journal of Pharmaceutical Sciences
参考文献36
-
1黄兰,周剑芳,韦红,舒跃龙.流感病毒神经氨酸酶抑制剂药物耐药现状及机制研究进展[J].病毒学报,2012,28(5):572-576. 被引量:24
-
2Calfee D, Hayden F. New approaches to influenza chemotherapy neuraminidase inhibitors [ J ]. Drugs, 1998,56 (4) :537 - 553.
-
3Meindl P, Bodo G, Lindner J, et al. Einfluss yon 2 - desoxy - 2,3 - dehydro - N - acetylneuramins ure auf myxovirus - neura- minidasen und die replikation yon influenza- und newcastle disease virus[ J]. Z Narurforsch B ,1971,26(8) :792-797.
-
4Goodford PJ. A computational procedure for determining energeti- cally favorable binding sites on biologically important macromole- cules [J]. J Med Chem,1985,28(7) :849 -857.
-
5Kim CU, Lew W, Williams MA, et al. Design, synthesis, and structural analysis of carbocyelic sialic acid analogues with potent anti - influenza activity [ J ]. J Am Chem Soc, 1997,119 (4) : 681 - 690.
-
6Marek JJ, Singh S, Brouillette W J, et al. Struetures of aromatic inhibitors of influenza virus neuraminidase [ J ]. Biochemistry, 1995,34(10) :3144 -3151.
-
7Williams M, Bischofberger N, Swaminathan S, et al. Synthesis and influenza neuraminidase inhibitory activity of aromatic ana- logues of sialic acid[ J ]. Bioorg Med Chem Lett, 1995,5 (19) : 2251 - 2254.
-
8Singh S,Jedrzejas MJ, Air GM, et al. Structure -based inhibi- tors of influenza virus sialidase. A benzoic acid lead with novel interaction[ J]. J Med Chem, 1995, 38 (17) : 3217 - 3225.
-
9Chand P, Babu YS, Bantia S, et al. Design and synthesis ofbenzoic acid derivatives as influenza neuraminidase inhibitors using structure - based drug design[J]. J Med Chem, 1997,40 (25) :4030 -4052.
-
10Atigadda VR, Brouillette WJ, Duarte F, et al. Potent inhibition of influenza sialidase by a benzoic acid containing a 2 - pyrmli- dine substituent [ J ]. J Med Chem, 1999,42 ( 13 ) :2332 - 2343.
二级参考文献28
-
1Von Itzstein M, Wu W Y, Kok G B, et al. Rational de- sign of potent sialidase-based inhibitors of influenza viru1 replication[J]. Nature,1993,363(6428) :418-423.
-
2Kim C U, Lew W, Williams M A, et al. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid ana- logues with potent anti-influenza activity [J]. J Am Chem Soc,1997,119(4) :681-690.
-
3Ikematsu H, Kawai N. Laninamivir octanoate., a new long-acting neuraminidase inhibitor for the treatment of influenza[J]. Expert Rev Anti Infect Ther,2011,9(10): 851-857.
-
4Stoner T D, Krauss S, Dubois R M, et ai. Antiviral susceptibility of avian and swine influenza virus of the N1 neuraminidase subtype[J]. J Virol, 2010,84 (19) 9800-9809.
-
5Chen H, Cheung C L, Tai H, et al. Oseltamivir-resist- ant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China[J]. Emerg Infect Dis,2009,15(12):1970- 1972.
-
6Le Q M, Wertheim H F, Tran N D, et al. A communi ty cluster of oseltamivir-resistant cases of 2009 ttlN1 influenza[J]. N Engl J Med,2010,362(1):86-87.
-
7Le Q M, Kiso M, Someya K, et al. Avian flu: isolation of drug-resistant HSN1 virus [J]. Nature, 2005, 437 (7062) : 1108-1108.
-
8Monto A S, Mckimm-Breschkiaa J L, Macken C, et al. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use[J]. Antimierob:gents Chemother, 2006,50 (7) :2395-2402.
-
9Nguyen H T, Fry A M, Gubareva L V. Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods[J]. Antivir Ther, 2012,17(1 Pt B): 159-173.
-
10Abed Y, Baz M, Boivin G. Impact of neuraminidase mutations conferring influenza resistance to neuramini- dase inhibitors in the N1 and N2 genetic backgrounds. [J]. Antivir Ther,2006,11(8) : 971-976.
共引文献23
-
1崔薇,孙炳欣,李晨光,李元果,初秋,张智丽,隋天卓,孙宇,张兴国.长春市2018-2020监测年度甲型H1N1流感病毒神经氨酸酶(NA)基因特征分析[J].中国实验诊断学,2022,26(2):235-240.
-
2陈寅,茅海燕,周敏,李榛,严菊英,张严峻,卢亦愚.浙江省近年甲型H1N1流感病毒神经氨酸酶基因序列分析[J].疾病监测,2013,28(10):811-814. 被引量:6
-
3谢剑锋,沈晓娜,王美爱,杨式芹,黄萌,张炎华,修文琼,翁育伟,严延生,郑奎城.福建省甲型H1N1流感病毒基因特征研究[J].病毒学报,2014,30(1):37-43. 被引量:9
-
4杨依兰,李兴旺.α干扰素治疗呼吸道病毒感染的研究进展[J].国际病毒学杂志,2018,25(6):426-429. 被引量:16
-
5赵玉梅,朱仁英,李海燕.抗流感类药物现况[J].中国公共卫生,2014,30(8):1097-1098. 被引量:3
-
6孙英峰,王利丽,路超,李秀丽,张莉,杨春蕾,冯婧,任卫科,田向学.硫酸酯化酵母β-葡聚糖对H1N1猪流感病毒血凝作用和mRNA转录的影响[J].华北农学报,2015,30(1):15-18. 被引量:2
-
7熊衍峰,李如,李健雄,施勇,胡晓军,龙彩云.赣州市2014年新型甲型H1N1流感病毒NA基因特征及耐药性分析[J].实验与检验医学,2016,34(4):458-460. 被引量:3
-
8史鹏辉,李剑波,梁广,张亚利,王晓龙,杨静,王升启.查尔酮类化合物L2H17对甲型流感病毒FM1株感染小鼠的保护作用[J].军事医学,2017,41(4):260-264. 被引量:1
-
9方丽.小儿热速清颗粒治疗儿童甲型流感风热犯卫证临床观察[J].新中医,2018,50(4):140-142. 被引量:10
-
10毛鑫,姚荣妹,高英杰,孙静,包蕾,曲天歌,时宇静,郭姗姗,崔晓兰.抗病毒口服液治疗甲型H1N1流感病毒感染药效及机制探讨[J].中国药物警戒,2018,15(9):518-522. 被引量:14
-
1胡静,王尔华.流感病毒神经氨酸酶抑制剂构效关系研究[J].药学进展,2004,28(5):204-208. 被引量:3
-
2张博,付杰,周永达,张剑波.流感病毒神经氨酸酶抑制剂的研究进展[J].天然产物研究与开发,2009,21(B05):253-257. 被引量:1
-
3张杰,徐文方.唾液酸类神经氨酸酶抑制剂的研究进展[J].中国医药工业杂志,2005,36(10):643-647. 被引量:6
-
4杜小莉,李大魁.神经氨酸酶抑制剂的研发及进展[J].世界医学杂志,2001,5(11):75-78.
-
5刘宗英,魏永刚,李卓荣.流感病毒神经氨酸酶抑制剂的合成筛选[J].中国抗生素杂志,2002,27(9):529-531. 被引量:3
-
6陶尚敏,陈文芳,陈蕾.侧脑室注射阿朴吗啡对大鼠血浆唾液酸水平的影响[J].青岛大学医学院学报,2000,36(2):117-118.
-
7刘艾林,杜冠华.流感病毒神经氨酸酶抑制剂的理性筛选[J].计算机与应用化学,2004,21(2):177-180. 被引量:4
-
8曹鸿鹏,陶佩珍,杜冠华.流感病毒神经氨酸酶抑制剂筛选模型的建立和应用[J].药学学报,2002,37(12):930-933. 被引量:32
-
9杨君义.流感病毒神经氨酸酶抑制剂[J].国外医药(抗生素分册),2001,22(3):131-133. 被引量:2
-
10杨荣成.选用口服神经氨酸酶抑制剂oseltamivir以预防流感[J].中华医学信息导报,2000,15(3):21-21.